DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Sangamo BioSciences, Inc. (SGMO)
« Back to company indexSGMO Chatter Timeline
Stock Ticker for SGMO
Most Active Tweeters for SGMO
| User | Tweets |
|---|---|
| @_B_I_O_T_E_C_H_ | 39 |
| @Biotech2050 | 18 |
| @JustTradingHoy | 17 |
| @rhoman1996 | 15 |
| @Jaytanoo | 15 |
Recent Tweets for SGMO
 |
@YuZhu4 RT @_B_I_O_T_E_C_H_: BB #Biotech reports: - disposal of Novo Nordisk and Achillion - #new positions in Kezar Life Science, $sgmo Sangamo a… January 18th 2019, 4:01pm |
 |
@TickerReport Sangamo Therapeutics Inc $SGMO Receives $18.80 Average Price Target from Brokerages https://t.co/d6ffC8LQvZ January 18th 2019, 3:01pm |
 |
@chrisoconnoriv RT @_B_I_O_T_E_C_H_: Jim Cramer at CNBC Mad Money: $SGMO https://t.co/9l5D0DfXZy January 18th 2019, 2:01pm |
 |
@biotech_junkie RT @_B_I_O_T_E_C_H_: Expect NEWS next week PREDICT TUMOR 1/22 Sumiti Jain $SGMO Highly Efficient Gene Modification Using #ZincFinger Nuclea… January 18th 2019, 1:01pm |
 |
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: Jim Cramer on $SGMO its a " #GAME #CHANGER " https://t.co/CGuPH0rvGn January 18th 2019, 1:01pm |
 |
@keitrader $SGMO looking finally good ~ big day on February 7 is approaching fast. January 18th 2019, 1:01pm |
 |
@OlympiaReport Zacks Investment Research Downgrades Sangamo Therapeutics $SGMO to Sell https://t.co/GxID6orDcE January 18th 2019, 1:01pm |
 |
@dispatchtribune Zacks Investment Research Downgrades Sangamo Therapeutics $SGMO to Sell https://t.co/szX5GptUMT January 18th 2019, 1:01pm |
 |
@twit_investr Lets get $SGMO -10% on stupid cramer pump... thinking of adding more before WORLD January 18th 2019, 9:01am |
|
@_B_I_O_T_E_C_H_ Expect NEWS next week PREDICT TUMOR 1/22 Sumiti Jain $SGMO Highly Efficient Gene Modification Using #ZincFinger Nuc… https://t.co/sItXCjUbW5 January 18th 2019, 9:01am |
 |
@McBurnMark RT @MichelDoepke: $SGMO is a new position of the portfolio from #BBBiotech. „Sangamo has improved zinc finger nuclease technology for gene… January 18th 2019, 9:01am |
 |
@yusufhameed $SGMO Hope Sangamo can weather the storm of failures recently, NOT to become the next $IMMU. @jimcramer likes the… https://t.co/2Uc9CVOT7o January 18th 2019, 9:01am |
 |
@ProVesting $SGMO $FCAU: Jim Cramer Advises His Viewers On Brink’s, Medtronic And More: https://t.co/cEDVuC4Snb January 18th 2019, 7:01am |
 |
@rhoman1996 @TraderSilver1 @_B_I_O_T_E_C_H_ $sgmo to answer ur question , i am still holding because i think the stock is going… https://t.co/CXMXrfbthH January 18th 2019, 7:01am |
|
@_B_I_O_T_E_C_H_ Jim Cramer on $SGMO its a " #GAME #CHANGER " https://t.co/CGuPH0rvGn January 18th 2019, 7:01am |
 |
@BehaviorFin $SGMO how do you see the future of Sangamo? January 18th 2019, 7:01am |
|
@rhoman1996 @TraderSilver1 @_B_I_O_T_E_C_H_ $sgmo why do you care ?? January 18th 2019, 6:01am |
|
@rhoman1996 @_B_I_O_T_E_C_H_ $sgmo you guys think i'm mush $sgmo just got kiss of death with cramer !! but he had said previous… https://t.co/UIV3iXxoD2 January 18th 2019, 6:01am |
|
@_B_I_O_T_E_C_H_ BB #Biotech reports: - disposal of Novo Nordisk and Achillion - #new positions in Kezar Life Science, $sgmo Sangamo and Audentes January 18th 2019, 4:01am |
|
@BehaviorFin RT @BehaviorFin: $SGMO Which will be sp at end of February, after world conference ? January 18th 2019, 3:01am |
 |
@Biotech2050 @MichelDoepke 0.5% of CHF3.06B in $SGMO = circa 1.4M shares bought by BB Biotech Fund January 18th 2019, 2:01am |
|
@_B_I_O_T_E_C_H_ Jim Cramer at CNBC Mad Money: $SGMO https://t.co/9l5D0DfXZy January 18th 2019, 1:01am |
|
@_B_I_O_T_E_C_H_ Jim Cramer at CNBC Mad Money says: $SGMO Sangamo Therapeutics Inc.: "It's a great spec. I mean, it really is. But,… https://t.co/INEJAOHBfW January 18th 2019, 1:01am |
 |
@MichelDoepke $SGMO is a new position of the portfolio from #BBBiotech. „Sangamo has improved zinc finger nuclease technology for… https://t.co/M96H5kBVdZ January 18th 2019, 1:01am |
 |
@Brian09816063 RT @wyv_123: $sgmo Not only did they lower the minimum age to 5 and allow females but they changed the inclusion criteria to be "MPS II" in… January 17th 2019, 7:01pm |
 |
@Kraigka RT @Jdalexander64: @_B_I_O_T_E_C_H_ $SGMO has to be demonstrating 1-Gene Editing occurring, 2-clear uGAGs reduction in adults, 3-plasma I… January 17th 2019, 1:01pm |
 |
@Jdalexander64 @_B_I_O_T_E_C_H_ $SGMO has to be demonstrating 1-Gene Editing occurring, 2-clear uGAGs reduction in adults, 3-pla… https://t.co/5reVDPlMbE January 17th 2019, 1:01pm |
 |
@wyv_123 It's about time they updated their own website. $SGMO @SangamoTx https://t.co/DLtyjMDMcB January 17th 2019, 1:01pm |
|
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: Updated #FDA Guidance on #drugdevelopment in rare diseases just released Pediatric Considerations re $SGMO AA https:/… January 17th 2019, 11:01am |
|
@Jdalexander64 I see highest return potential 1-2x in 2019 - $AITB (PPHN deal/Nasdaq listing/PPHN FDA 510k approval), $SGMO (platf… https://t.co/BuVFhPO3yt January 17th 2019, 9:01am |
 |
@TranscriptDaily Sangamo Therapeutics Inc $SGMO Expected to Announce Earnings of -$0.20 Per Share https://t.co/mQ6siLSlmR January 17th 2019, 9:01am |
|
@_B_I_O_T_E_C_H_ Updated #FDA Guidance on #drugdevelopment in rare diseases just released Pediatric Considerations re $SGMO AA https://t.co/T7mrpkLryv January 17th 2019, 9:01am |
 |
@AviseAnalytics RT @reurope_stock: Sangamo Biosciences Inc $SGMO Shifting Institutional Investors Sentiment https://t.co/SAZIFR6hFq January 17th 2019, 9:01am |
 |
@realTorontoTru2 $SGMO looks like it may be breaking out? if anyone wants to educate me on what I see feel free. https://t.co/8T215QY0eW January 17th 2019, 8:01am |
 |
@reurope_stock Sangamo Biosciences Inc $SGMO Shifting Institutional Investors Sentiment https://t.co/SAZIFR6hFq January 17th 2019, 8:01am |
 |
@JustTradingHoy $SGMO maybe figure they need better communications https://t.co/duJuI9dO1x January 17th 2019, 7:01am |
 |
@mmahotstuff1 After Forming Double Bottom Chart Pattern, Is Sangamo Therapeutics, Inc. $SGMO's Near-Term Analysis Negative? https://t.co/TMcW03Kl3g January 17th 2019, 6:01am |
 |
@whatsonthorold2 Some Traders Are Very Bearish on Sangamo Therapeutics, Inc. $SGMO After Forming Double Bottom Pattern https://t.co/59v3ZDMJeH January 17th 2019, 6:01am |
 |
@bibeypost_stock Sangamo Therapeutics, Inc. $SGMO Stock Formed Double Bottom. What To Expect? https://t.co/erjY8zLxLi January 17th 2019, 6:01am |
|
@reurope_stock It Seems Sangamo Therapeutics, Inc. $SGMO Will Go Down. Formed A Few Months Double Bottom Pattern https://t.co/o4LWmKDYfM January 17th 2019, 6:01am |
 |
@seajuno_ $SGMO Has been designated by the market to be “show-me stock” where it will remain until it explicitly proves other… https://t.co/WRfHlec8Av January 17th 2019, 1:01am |
 |
@AmericanBanking Kathy Yi Sells 5,000 Shares of Sangamo Therapeutics Inc $SGMO Stock https://t.co/ITgPFyWW92 #stocks January 16th 2019, 7:01pm |
|
@dakotafinancial Kathy Yi Sells 5,000 Shares of Sangamo Therapeutics Inc $SGMO Stock https://t.co/bknReuQGdn January 16th 2019, 7:01pm |
 |
@macondailynews Sangamo Therapeutics Inc $SGMO CFO Sells $55,200.00 in Stock https://t.co/pm58TvPRHC January 16th 2019, 7:01pm |
 |
@DarrenEstes @BoisselStephane And likely to all be from $SGMO. ? January 16th 2019, 6:01pm |
 |
@confcalltran Sangamo BioSciences's SVP %26 Chief Financial Officer just cashed-in 5,000 options https://t.co/Wi2OiAzU2g $SGMO January 16th 2019, 4:01pm |
 |
@heyjt55 RT @Biotech2050: If it wasn’t for blatant manipulation $SGMO would be trading >$50 on the FDA guidance https://t.co/3ePgLv3qKo January 16th 2019, 4:01pm |
 |
@VisualStockRSRC $SGMO - Statement of Changes in Beneficial Ownership (4) https://t.co/3BNXs5xTQO January 16th 2019, 4:01pm |
|
@heyjt55 RT @_B_I_O_T_E_C_H_: $SGMO #CROI19 Conference March 4 Update on #HIV #Cure Update on HIV Cure Katharine J. Bar, University of Pennsylvan… January 16th 2019, 3:01pm |
|
@_B_I_O_T_E_C_H_ $SGMO #CROI19 Conference March 4 Update on #HIV #Cure Update on HIV Cure Katharine J. Bar, University of Pennsyl… https://t.co/L1vdRxG3vX January 16th 2019, 3:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.